The Pennant Group, Inc. (NASDAQ: PNTG) Stock Competitors & Peer Comparison
See PNTG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for PNTG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| PNTG | $41.16 | +3.39% | 1.4B | 33.46 | $1.23 | N/A |
| HCA | $382.19 | +1.51% | 84.8B | 13.20 | $28.96 | +0.78% |
| THC | $233.20 | +17.17% | 20.1B | 13.53 | $17.24 | N/A |
| DVA | $235.44 | +0.50% | 15.1B | 20.06 | $11.73 | N/A |
| SOLV | $78.01 | +1.00% | 13.5B | 12.50 | $6.24 | N/A |
| FMS | $24.59 | +0.61% | 13.2B | 9.76 | $2.52 | +3.52% |
| EHC | $112.89 | +1.65% | 11.2B | 19.83 | $5.69 | +0.67% |
| ENSG | $172.99 | +3.27% | 10.1B | 25.07 | $6.90 | +0.15% |
| UHS | $155.75 | +2.96% | 9.8B | 6.91 | $22.54 | +0.51% |
| OSH | $39.00 | +0.08% | 9.5B | -17.65 | -$2.21 | N/A |
Stock Comparison
HCA Healthcare, Inc. (NYSE: HCA)
PNTG vs HCA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, HCA has a market cap of 84.8B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while HCA trades at $382.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas HCA's P/E ratio is 13.20. In terms of profitability, PNTG's ROE is +0.09%, compared to HCA's ROE of -1.54%. Regarding short-term risk, PNTG is less volatile compared to HCA. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check HCA's competition here
Tenet Healthcare Corporation (NYSE: THC)
PNTG vs THC Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, THC has a market cap of 20.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while THC trades at $233.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas THC's P/E ratio is 13.53. In terms of profitability, PNTG's ROE is +0.09%, compared to THC's ROE of +0.38%. Regarding short-term risk, PNTG is less volatile compared to THC. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check THC's competition here
DaVita Inc. (NYSE: DVA)
PNTG vs DVA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, DVA has a market cap of 15.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while DVA trades at $235.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas DVA's P/E ratio is 20.06. In terms of profitability, PNTG's ROE is +0.09%, compared to DVA's ROE of -1.33%. Regarding short-term risk, PNTG is more volatile compared to DVA. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check DVA's competition here
Solventum Corporation (NYSE: SOLV)
PNTG vs SOLV Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SOLV has a market cap of 13.5B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SOLV trades at $78.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SOLV's P/E ratio is 12.50. In terms of profitability, PNTG's ROE is +0.09%, compared to SOLV's ROE of +0.31%. Regarding short-term risk, PNTG is more volatile compared to SOLV. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check SOLV's competition here
Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)
PNTG vs FMS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, FMS has a market cap of 13.2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while FMS trades at $24.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas FMS's P/E ratio is 9.76. In terms of profitability, PNTG's ROE is +0.09%, compared to FMS's ROE of +0.07%. Regarding short-term risk, PNTG is more volatile compared to FMS. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check FMS's competition here
Encompass Health Corporation (NYSE: EHC)
PNTG vs EHC Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, EHC has a market cap of 11.2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while EHC trades at $112.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas EHC's P/E ratio is 19.83. In terms of profitability, PNTG's ROE is +0.09%, compared to EHC's ROE of +0.25%. Regarding short-term risk, PNTG is more volatile compared to EHC. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check EHC's competition here
The Ensign Group, Inc. (NASDAQ: ENSG)
PNTG vs ENSG Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ENSG has a market cap of 10.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ENSG trades at $172.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ENSG's P/E ratio is 25.07. In terms of profitability, PNTG's ROE is +0.09%, compared to ENSG's ROE of +0.17%. Regarding short-term risk, PNTG is more volatile compared to ENSG. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check ENSG's competition here
Universal Health Services, Inc. (NYSE: UHS)
PNTG vs UHS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, UHS has a market cap of 9.8B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while UHS trades at $155.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas UHS's P/E ratio is 6.91. In terms of profitability, PNTG's ROE is +0.09%, compared to UHS's ROE of +0.21%. Regarding short-term risk, PNTG is more volatile compared to UHS. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check UHS's competition here
Oak Street Health, Inc. (NYSE: OSH)
PNTG vs OSH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, OSH has a market cap of 9.5B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while OSH trades at $39.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas OSH's P/E ratio is -17.65. In terms of profitability, PNTG's ROE is +0.09%, compared to OSH's ROE of +4.64%. Regarding short-term risk, PNTG is more volatile compared to OSH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check OSH's competition here
PACS Group, Inc. (NYSE: PACS)
PNTG vs PACS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, PACS has a market cap of 7.4B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while PACS trades at $46.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas PACS's P/E ratio is 39.80. In terms of profitability, PNTG's ROE is +0.09%, compared to PACS's ROE of +0.27%. Regarding short-term risk, PNTG is less volatile compared to PACS. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check PACS's competition here
Chemed Corporation (NYSE: CHE)
PNTG vs CHE Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CHE has a market cap of 6.8B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CHE trades at $511.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CHE's P/E ratio is 23.66. In terms of profitability, PNTG's ROE is +0.09%, compared to CHE's ROE of +0.25%. Regarding short-term risk, PNTG is more volatile compared to CHE. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check CHE's competition here
LHC Group, Inc. (NASDAQ: LHCG)
PNTG vs LHCG Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, LHCG has a market cap of 5.3B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while LHCG trades at $169.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas LHCG's P/E ratio is 82.83. In terms of profitability, PNTG's ROE is +0.09%, compared to LHCG's ROE of +0.04%. Regarding short-term risk, PNTG is more volatile compared to LHCG. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check LHCG's competition here
LifeStance Health Group, Inc. (NASDAQ: LFST)
PNTG vs LFST Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, LFST has a market cap of 4.2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while LFST trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas LFST's P/E ratio is 173.65. In terms of profitability, PNTG's ROE is +0.09%, compared to LFST's ROE of +0.02%. Regarding short-term risk, PNTG is more volatile compared to LFST. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check LFST's competition here
Concentra Group Holdings Parent, Inc. (NYSE: CON)
PNTG vs CON Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CON has a market cap of 4B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CON trades at $31.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CON's P/E ratio is 21.95. In terms of profitability, PNTG's ROE is +0.09%, compared to CON's ROE of +0.46%. Regarding short-term risk, PNTG is more volatile compared to CON. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check CON's competition here
Brookdale Senior Living Inc. (NYSE: BKD)
PNTG vs BKD Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, BKD has a market cap of 3.6B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while BKD trades at $15.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas BKD's P/E ratio is -26.11. In terms of profitability, PNTG's ROE is +0.09%, compared to BKD's ROE of +401.19%. Regarding short-term risk, PNTG is more volatile compared to BKD. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check BKD's competition here
National HealthCare Corporation (AMEX: NHC)
PNTG vs NHC Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, NHC has a market cap of 3.5B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while NHC trades at $225.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas NHC's P/E ratio is 32.32. In terms of profitability, PNTG's ROE is +0.09%, compared to NHC's ROE of +0.12%. Regarding short-term risk, PNTG is more volatile compared to NHC. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check NHC's competition here
Option Care Health, Inc. (NASDAQ: OPCH)
PNTG vs OPCH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, OPCH has a market cap of 3.4B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while OPCH trades at $21.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas OPCH's P/E ratio is 12.59. In terms of profitability, PNTG's ROE is +0.09%, compared to OPCH's ROE of +0.15%. Regarding short-term risk, PNTG is more volatile compared to OPCH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check OPCH's competition here
Amedisys, Inc. (NASDAQ: AMED)
PNTG vs AMED Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AMED has a market cap of 3.3B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AMED trades at $100.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AMED's P/E ratio is 39.30. In terms of profitability, PNTG's ROE is +0.09%, compared to AMED's ROE of +0.11%. Regarding short-term risk, PNTG is more volatile compared to AMED. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AMED's competition here
Acadia Healthcare Company, Inc. (NASDAQ: ACHC)
PNTG vs ACHC Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ACHC has a market cap of 3.2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ACHC trades at $34.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ACHC's P/E ratio is 17.34. In terms of profitability, PNTG's ROE is +0.09%, compared to ACHC's ROE of -0.44%. Regarding short-term risk, PNTG is more volatile compared to ACHC. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check ACHC's competition here
Pediatrix Medical Group, Inc. (NYSE: MD)
PNTG vs MD Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, MD has a market cap of 2.2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while MD trades at $26.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas MD's P/E ratio is 12.27. In terms of profitability, PNTG's ROE is +0.09%, compared to MD's ROE of +0.20%. Regarding short-term risk, PNTG is more volatile compared to MD. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check MD's competition here
Addus HomeCare Corporation (NASDAQ: ADUS)
PNTG vs ADUS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ADUS has a market cap of 2.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ADUS trades at $114.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ADUS's P/E ratio is 17.79. In terms of profitability, PNTG's ROE is +0.09%, compared to ADUS's ROE of +0.09%. Regarding short-term risk, PNTG is more volatile compared to ADUS. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check ADUS's competition here
Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH)
PNTG vs AVAH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AVAH has a market cap of 2.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AVAH trades at $9.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AVAH's P/E ratio is 13.90. In terms of profitability, PNTG's ROE is +0.09%, compared to AVAH's ROE of +2.41%. Regarding short-term risk, PNTG is more volatile compared to AVAH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AVAH's competition here
Surgery Partners, Inc. (NASDAQ: SGRY)
PNTG vs SGRY Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SGRY has a market cap of 2.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SGRY trades at $15.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SGRY's P/E ratio is 40.33. In terms of profitability, PNTG's ROE is +0.09%, compared to SGRY's ROE of -0.04%. Regarding short-term risk, PNTG is less volatile compared to SGRY. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check SGRY's competition here
Select Medical Holdings Corporation (NYSE: SEM)
PNTG vs SEM Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SEM has a market cap of 2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SEM trades at $16.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SEM's P/E ratio is 15.43. In terms of profitability, PNTG's ROE is +0.09%, compared to SEM's ROE of +0.08%. Regarding short-term risk, PNTG is more volatile compared to SEM. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check SEM's competition here
Astrana Health, Inc. (NASDAQ: ASTH)
PNTG vs ASTH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ASTH has a market cap of 2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ASTH trades at $40.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ASTH's P/E ratio is 27.24. In terms of profitability, PNTG's ROE is +0.09%, compared to ASTH's ROE of +0.04%. Regarding short-term risk, PNTG is more volatile compared to ASTH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check ASTH's competition here
Apollo Medical Holdings, Inc. (NASDAQ: AMEH)
PNTG vs AMEH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AMEH has a market cap of 1.8B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AMEH trades at $40.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AMEH's P/E ratio is 39.25. In terms of profitability, PNTG's ROE is +0.09%, compared to AMEH's ROE of +0.04%. Regarding short-term risk, PNTG is more volatile compared to AMEH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AMEH's competition here
Agilon Health, Inc. (NYSE: AGL)
PNTG vs AGL Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AGL has a market cap of 1.6B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AGL trades at $98.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AGL's P/E ratio is -9.57. In terms of profitability, PNTG's ROE is +0.09%, compared to AGL's ROE of -1.46%. Regarding short-term risk, PNTG is less volatile compared to AGL. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check AGL's competition here
Innovage Holding Corp. (NASDAQ: INNV)
PNTG vs INNV Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, INNV has a market cap of 1.6B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while INNV trades at $11.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas INNV's P/E ratio is -128.44. In terms of profitability, PNTG's ROE is +0.09%, compared to INNV's ROE of -0.09%. Regarding short-term risk, PNTG is more volatile compared to INNV. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check INNV's competition here
Healthcare Services Group, Inc. (NASDAQ: HCSG)
PNTG vs HCSG Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, HCSG has a market cap of 1.6B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while HCSG trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas HCSG's P/E ratio is 18.19. In terms of profitability, PNTG's ROE is +0.09%, compared to HCSG's ROE of +0.23%. Regarding short-term risk, PNTG is more volatile compared to HCSG. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check HCSG's competition here
Ardent Health Inc. (NYSE: ARDT)
PNTG vs ARDT Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ARDT has a market cap of 1.5B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ARDT trades at $10.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ARDT's P/E ratio is 6.47. In terms of profitability, PNTG's ROE is +0.09%, compared to ARDT's ROE of +0.09%. Regarding short-term risk, PNTG is less volatile compared to ARDT. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check ARDT's competition here
AMN Healthcare Services, Inc. (NYSE: AMN)
PNTG vs AMN Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AMN has a market cap of 1.3B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AMN trades at $32.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AMN's P/E ratio is 10.93. In terms of profitability, PNTG's ROE is +0.09%, compared to AMN's ROE of -0.05%. Regarding short-term risk, PNTG is more volatile compared to AMN. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AMN's competition here
Brookdale Senior Living Inc. 7. (NYSE: BKDT)
PNTG vs BKDT Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, BKDT has a market cap of 1.2B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while BKDT trades at $77.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas BKDT's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to BKDT's ROE of +401.19%. Regarding short-term risk, PNTG is more volatile compared to BKDT. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check BKDT's competition here
U.S. Physical Therapy, Inc. (NYSE: USPH)
PNTG vs USPH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, USPH has a market cap of 1.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while USPH trades at $74.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas USPH's P/E ratio is 28.74. In terms of profitability, PNTG's ROE is +0.09%, compared to USPH's ROE of +0.00%. Regarding short-term risk, PNTG is more volatile compared to USPH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check USPH's competition here
COMPASS Pathways plc (NASDAQ: CMPS)
PNTG vs CMPS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CMPS has a market cap of 1.1B. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CMPS trades at $11.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CMPS's P/E ratio is -5.49. In terms of profitability, PNTG's ROE is +0.09%, compared to CMPS's ROE of -1.51%. Regarding short-term risk, PNTG is less volatile compared to CMPS. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check CMPS's competition here
Fidelity Select Health Care Svcs Port (NASDAQ: FSHCX)
PNTG vs FSHCX Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, FSHCX has a market cap of 882M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while FSHCX trades at $120.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas FSHCX's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to FSHCX's ROE of N/A. Regarding short-term risk, PNTG is more volatile compared to FSHCX. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check FSHCX's competition here
Talkspace, Inc. (NASDAQ: TALKW)
PNTG vs TALKW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TALKW has a market cap of 874.4M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TALKW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TALKW's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to TALKW's ROE of +0.01%. Regarding short-term risk, PNTG is less volatile compared to TALKW. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check TALKW's competition here
Talkspace, Inc. (NASDAQ: TALK)
PNTG vs TALK Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TALK has a market cap of 872.7M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TALK trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TALK's P/E ratio is 768.44. In terms of profitability, PNTG's ROE is +0.09%, compared to TALK's ROE of +0.01%. Regarding short-term risk, PNTG is more volatile compared to TALK. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check TALK's competition here
Nutex Health, Inc. (NASDAQ: NUTX)
PNTG vs NUTX Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, NUTX has a market cap of 868.6M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while NUTX trades at $145.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas NUTX's P/E ratio is 11.27. In terms of profitability, PNTG's ROE is +0.09%, compared to NUTX's ROE of +0.31%. Regarding short-term risk, PNTG is less volatile compared to NUTX. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check NUTX's competition here
Sonida Senior Living, Inc. (NYSE: SNDA)
PNTG vs SNDA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SNDA has a market cap of 833.8M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SNDA trades at $41.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SNDA's P/E ratio is -7.72. In terms of profitability, PNTG's ROE is +0.09%, compared to SNDA's ROE of -0.35%. Regarding short-term risk, PNTG is more volatile compared to SNDA. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check SNDA's competition here
Enhabit, Inc. (NYSE: EHAB)
PNTG vs EHAB Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, EHAB has a market cap of 706.9M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while EHAB trades at $13.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas EHAB's P/E ratio is -197.14. In terms of profitability, PNTG's ROE is +0.09%, compared to EHAB's ROE of -0.01%. Regarding short-term risk, PNTG is more volatile compared to EHAB. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check EHAB's competition here
GMR Solutions Inc. (NYSE: GMRS)
PNTG vs GMRS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, GMRS has a market cap of 594M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while GMRS trades at $12.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas GMRS's P/E ratio is 5.76. In terms of profitability, PNTG's ROE is +0.09%, compared to GMRS's ROE of +1.01%. Regarding short-term risk, PNTG is more volatile compared to GMRS. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check GMRS's competition here
The Oncology Institute, Inc. (NASDAQ: TOI)
PNTG vs TOI Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TOI has a market cap of 497.9M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TOI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TOI's P/E ratio is -13.83. In terms of profitability, PNTG's ROE is +0.09%, compared to TOI's ROE of +3.27%. Regarding short-term risk, PNTG is more volatile compared to TOI. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check TOI's competition here
Viemed Healthcare, Inc. (NASDAQ: VMD)
PNTG vs VMD Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, VMD has a market cap of 451.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while VMD trades at $11.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas VMD's P/E ratio is 31.81. In terms of profitability, PNTG's ROE is +0.09%, compared to VMD's ROE of +0.11%. Regarding short-term risk, PNTG is more volatile compared to VMD. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check VMD's competition here
Charming Medical Limited Class A Ordinary Shares (NASDAQ: MCTA)
PNTG vs MCTA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, MCTA has a market cap of 445.6M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while MCTA trades at $29.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas MCTA's P/E ratio is 419.36. In terms of profitability, PNTG's ROE is +0.09%, compared to MCTA's ROE of -2.33%. Regarding short-term risk, PNTG is more volatile compared to MCTA. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check MCTA's competition here
Strata Critical Medical, Inc. (NASDAQ: SRTA)
PNTG vs SRTA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SRTA has a market cap of 436.1M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SRTA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SRTA's P/E ratio is -35.46. In terms of profitability, PNTG's ROE is +0.09%, compared to SRTA's ROE of +0.18%. Regarding short-term risk, PNTG is more volatile compared to SRTA. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check SRTA's competition here
The Oncology Institute, Inc. (NASDAQ: TOIIW)
PNTG vs TOIIW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TOIIW has a market cap of 388.9M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TOIIW trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TOIIW's P/E ratio is -0.18. In terms of profitability, PNTG's ROE is +0.09%, compared to TOIIW's ROE of +3.27%. Regarding short-term risk, PNTG is less volatile compared to TOIIW. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check TOIIW's competition here
Community Health Systems, Inc. (NYSE: CYH)
PNTG vs CYH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CYH has a market cap of 384M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CYH trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CYH's P/E ratio is 3.73. In terms of profitability, PNTG's ROE is +0.09%, compared to CYH's ROE of +0.21%. Regarding short-term risk, PNTG is less volatile compared to CYH. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check CYH's competition here
Auna S.A. (NYSE: AUNA)
PNTG vs AUNA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AUNA has a market cap of 373.8M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AUNA trades at $5.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AUNA's P/E ratio is 4.55. In terms of profitability, PNTG's ROE is +0.09%, compared to AUNA's ROE of +0.04%. Regarding short-term risk, PNTG is less volatile compared to AUNA. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check AUNA's competition here
AirSculpt Technologies, Inc. (NASDAQ: AIRS)
PNTG vs AIRS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AIRS has a market cap of 325.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AIRS trades at $4.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AIRS's P/E ratio is -153.67. In terms of profitability, PNTG's ROE is +0.09%, compared to AIRS's ROE of -0.12%. Regarding short-term risk, PNTG is more volatile compared to AIRS. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AIRS's competition here
Capital Senior Living Corporation (NYSE: CSU)
PNTG vs CSU Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CSU has a market cap of 223.7M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CSU trades at $33.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CSU's P/E ratio is 0.67. In terms of profitability, PNTG's ROE is +0.09%, compared to CSU's ROE of -0.51%. Regarding short-term risk, PNTG is more volatile compared to CSU. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check CSU's competition here
The Joint Corp. (NASDAQ: JYNT)
PNTG vs JYNT Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, JYNT has a market cap of 119M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while JYNT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas JYNT's P/E ratio is 83.50. In terms of profitability, PNTG's ROE is +0.09%, compared to JYNT's ROE of +0.17%. Regarding short-term risk, PNTG is more volatile compared to JYNT. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check JYNT's competition here
biote Corp. (NASDAQ: BTMD)
PNTG vs BTMD Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, BTMD has a market cap of 100.6M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while BTMD trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas BTMD's P/E ratio is 5.18. In terms of profitability, PNTG's ROE is +0.09%, compared to BTMD's ROE of -0.23%. Regarding short-term risk, PNTG is more volatile compared to BTMD. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check BTMD's competition here
Five Star Senior Living Inc. (NASDAQ: FVE)
PNTG vs FVE Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, FVE has a market cap of 98.4M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while FVE trades at $2.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas FVE's P/E ratio is -5.64. In terms of profitability, PNTG's ROE is +0.09%, compared to FVE's ROE of -0.15%. Regarding short-term risk, PNTG is more volatile compared to FVE. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check FVE's competition here
Kindly MD, Inc. (NASDAQ: KDLYW)
PNTG vs KDLYW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, KDLYW has a market cap of 96.5M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while KDLYW trades at $18.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas KDLYW's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to KDLYW's ROE of -0.85%. Regarding short-term risk, PNTG is less volatile compared to KDLYW. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check KDLYW's competition here
DocGo Inc. (NASDAQ: DCGO)
PNTG vs DCGO Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, DCGO has a market cap of 58.9M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while DCGO trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas DCGO's P/E ratio is -0.68. In terms of profitability, PNTG's ROE is +0.09%, compared to DCGO's ROE of -0.89%. Regarding short-term risk, PNTG is less volatile compared to DCGO. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check DCGO's competition here
AlerisLife Inc. (NASDAQ: ALR)
PNTG vs ALR Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ALR has a market cap of 44.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ALR trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ALR's P/E ratio is -1.11. In terms of profitability, PNTG's ROE is +0.09%, compared to ALR's ROE of -0.15%. Regarding short-term risk, PNTG is more volatile compared to ALR. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check ALR's competition here
Park Dental Partners, Inc. Common Stock (NASDAQ: PARK)
PNTG vs PARK Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, PARK has a market cap of 36.5M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while PARK trades at $18.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas PARK's P/E ratio is 25.36. In terms of profitability, PNTG's ROE is +0.09%, compared to PARK's ROE of -0.24%. Regarding short-term risk, PNTG is less volatile compared to PARK. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check PARK's competition here
IMAC Holdings, Inc. (NASDAQ: IMAC)
PNTG vs IMAC Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, IMAC has a market cap of 33.1M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while IMAC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas IMAC's P/E ratio is -2.27. In terms of profitability, PNTG's ROE is +0.09%, compared to IMAC's ROE of +0.00%. Regarding short-term risk, PNTG is more volatile compared to IMAC. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check IMAC's competition here
P3 Health Partners Inc. (NASDAQ: PIII)
PNTG vs PIII Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, PIII has a market cap of 31.5M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while PIII trades at $9.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas PIII's P/E ratio is -0.24. In terms of profitability, PNTG's ROE is +0.09%, compared to PIII's ROE of +1.85%. Regarding short-term risk, PNTG is less volatile compared to PIII. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check PIII's competition here
Cryo-Cell International, Inc. (AMEX: CCEL)
PNTG vs CCEL Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CCEL has a market cap of 28.1M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CCEL trades at $3.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CCEL's P/E ratio is -10.55. In terms of profitability, PNTG's ROE is +0.09%, compared to CCEL's ROE of +0.14%. Regarding short-term risk, PNTG is more volatile compared to CCEL. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check CCEL's competition here
Cano Health, Inc. (NYSE: CANO-WT)
PNTG vs CANO-WT Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CANO-WT has a market cap of 19.3M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CANO-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CANO-WT's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to CANO-WT's ROE of -1.49%. Regarding short-term risk, PNTG is less volatile compared to CANO-WT. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check CANO-WT's competition here
Aesthetic Medical International Holdings Group Limited (NASDAQ: AIH)
PNTG vs AIH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AIH has a market cap of 15.9M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AIH trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AIH's P/E ratio is -2.78. In terms of profitability, PNTG's ROE is +0.09%, compared to AIH's ROE of +1.16%. Regarding short-term risk, PNTG is less volatile compared to AIH. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check AIH's competition here
Cano Health, Inc. (NYSE: CANO)
PNTG vs CANO Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CANO has a market cap of 12.4M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CANO trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CANO's P/E ratio is -0.01. In terms of profitability, PNTG's ROE is +0.09%, compared to CANO's ROE of -1.49%. Regarding short-term risk, PNTG is less volatile compared to CANO. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check CANO's competition here
Avem Health Partners, Inc. (NYSE: FPCG)
PNTG vs FPCG Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, FPCG has a market cap of 10.1M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas FPCG's P/E ratio is 0.09. In terms of profitability, PNTG's ROE is +0.09%, compared to FPCG's ROE of +0.00%. Regarding short-term risk, PNTG is more volatile compared to FPCG. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check FPCG's competition here
Field Trip Health Ltd. (NASDAQ: FTRP)
PNTG vs FTRP Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, FTRP has a market cap of 9.8M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while FTRP trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas FTRP's P/E ratio is -1.22. In terms of profitability, PNTG's ROE is +0.09%, compared to FTRP's ROE of -0.62%. Regarding short-term risk, PNTG is more volatile compared to FTRP. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check FTRP's competition here
American Shared Hospital Services (AMEX: AMS)
PNTG vs AMS Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AMS has a market cap of 9.5M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AMS trades at $1.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AMS's P/E ratio is -6.47. In terms of profitability, PNTG's ROE is +0.09%, compared to AMS's ROE of -0.06%. Regarding short-term risk, PNTG is more volatile compared to AMS. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AMS's competition here
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL)
PNTG vs BMGL Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, BMGL has a market cap of 9.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while BMGL trades at $5.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas BMGL's P/E ratio is -1.11. In terms of profitability, PNTG's ROE is +0.09%, compared to BMGL's ROE of -1.74%. Regarding short-term risk, PNTG is less volatile compared to BMGL. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check BMGL's competition here
XWELL, Inc. (NASDAQ: XWEL)
PNTG vs XWEL Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, XWEL has a market cap of 6.4M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while XWEL trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas XWEL's P/E ratio is -0.32. In terms of profitability, PNTG's ROE is +0.09%, compared to XWEL's ROE of +2.89%. Regarding short-term risk, PNTG is more volatile compared to XWEL. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check XWEL's competition here
ModivCare Inc. (NASDAQ: MODV)
PNTG vs MODV Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, MODV has a market cap of 6.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while MODV trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas MODV's P/E ratio is -0.06. In terms of profitability, PNTG's ROE is +0.09%, compared to MODV's ROE of +1.36%. Regarding short-term risk, PNTG is more volatile compared to MODV. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check MODV's competition here
Greenbrook TMS Inc. (NASDAQ: GBNH)
PNTG vs GBNH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, GBNH has a market cap of 5.5M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while GBNH trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas GBNH's P/E ratio is -0.06. In terms of profitability, PNTG's ROE is +0.09%, compared to GBNH's ROE of +15.74%. Regarding short-term risk, PNTG is less volatile compared to GBNH. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check GBNH's competition here
Regional Health Properties, Inc. (AMEX: RHE-PA)
PNTG vs RHE-PA Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, RHE-PA has a market cap of 5.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while RHE-PA trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas RHE-PA's P/E ratio is -0.09. In terms of profitability, PNTG's ROE is +0.09%, compared to RHE-PA's ROE of +2.11%. Regarding short-term risk, PNTG is less volatile compared to RHE-PA. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check RHE-PA's competition here
Regional Health Properties, Inc. (AMEX: RHE)
PNTG vs RHE Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, RHE has a market cap of 5.2M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while RHE trades at $2.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas RHE's P/E ratio is -1.79. In terms of profitability, PNTG's ROE is +0.09%, compared to RHE's ROE of -0.36%. Regarding short-term risk, PNTG is less volatile compared to RHE. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check RHE's competition here
20/20 Biolabs Inc. (NASDAQ: AIDX)
PNTG vs AIDX Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AIDX has a market cap of 2.8M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AIDX trades at $0.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AIDX's P/E ratio is -0.93. In terms of profitability, PNTG's ROE is +0.09%, compared to AIDX's ROE of +0.79%. Regarding short-term risk, PNTG is more volatile compared to AIDX. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AIDX's competition here
IMAC Holdings, Inc. (NASDAQ: IMACW)
PNTG vs IMACW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, IMACW has a market cap of 1.7M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while IMACW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas IMACW's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to IMACW's ROE of +0.73%. Regarding short-term risk, PNTG is less volatile compared to IMACW. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check IMACW's competition here
Nakamoto Inc. (NASDAQ: NAKAW)
PNTG vs NAKAW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, NAKAW has a market cap of 1.5M. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while NAKAW trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas NAKAW's P/E ratio is -0.53. In terms of profitability, PNTG's ROE is +0.09%, compared to NAKAW's ROE of -0.85%. Regarding short-term risk, PNTG is more volatile compared to NAKAW. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check NAKAW's competition here
Concord Medical Services Holdings Limited (NYSE: CCM)
PNTG vs CCM Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, CCM has a market cap of 626.1K. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while CCM trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas CCM's P/E ratio is -0.29. In terms of profitability, PNTG's ROE is +0.09%, compared to CCM's ROE of +0.06%. Regarding short-term risk, PNTG is less volatile compared to CCM. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check CCM's competition here
NewGenIvf Group Limited (NASDAQ: NIVF)
PNTG vs NIVF Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, NIVF has a market cap of 212.3K. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while NIVF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas NIVF's P/E ratio is 0.55. In terms of profitability, PNTG's ROE is +0.09%, compared to NIVF's ROE of +0.33%. Regarding short-term risk, PNTG is less volatile compared to NIVF. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check NIVF's competition here
Mobile-health Network Solutions Class A Ordinary Shares (NASDAQ: MNDR)
PNTG vs MNDR Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, MNDR has a market cap of 53.6K. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while MNDR trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas MNDR's P/E ratio is -0.05. In terms of profitability, PNTG's ROE is +0.09%, compared to MNDR's ROE of -0.46%. Regarding short-term risk, PNTG is less volatile compared to MNDR. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check MNDR's competition here
NewGenIvf Group Limited (NASDAQ: NIVFW)
PNTG vs NIVFW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, NIVFW has a market cap of 50K. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while NIVFW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas NIVFW's P/E ratio is -0.01. In terms of profitability, PNTG's ROE is +0.09%, compared to NIVFW's ROE of +0.33%. Regarding short-term risk, PNTG is less volatile compared to NIVFW. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check NIVFW's competition here
DocGo Inc. (NASDAQ: DCGOW)
PNTG vs DCGOW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, DCGOW has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while DCGOW trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas DCGOW's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to DCGOW's ROE of -0.89%. Regarding short-term risk, PNTG is less volatile compared to DCGOW. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check DCGOW's competition here
SOC Telemed, Inc. (NASDAQ: TLMDW)
PNTG vs TLMDW Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TLMDW has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TLMDW trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TLMDW's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to TLMDW's ROE of -0.46%. Regarding short-term risk, PNTG is more volatile compared to TLMDW. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check TLMDW's competition here
Hanger, Inc. (NYSE: HNGR)
PNTG vs HNGR Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, HNGR has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while HNGR trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas HNGR's P/E ratio is 19.71. In terms of profitability, PNTG's ROE is +0.09%, compared to HNGR's ROE of +0.52%. Regarding short-term risk, PNTG is more volatile compared to HNGR. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check HNGR's competition here
ATI Physical Therapy, Inc. (NYSE: ATIP-WT)
PNTG vs ATIP-WT Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, ATIP-WT has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while ATIP-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas ATIP-WT's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to ATIP-WT's ROE of +2.05%. Regarding short-term risk, PNTG is less volatile compared to ATIP-WT. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check ATIP-WT's competition here
Tivity Health, Inc. (NASDAQ: TVTY)
PNTG vs TVTY Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TVTY has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TVTY trades at $32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TVTY's P/E ratio is 19.06. In terms of profitability, PNTG's ROE is +0.09%, compared to TVTY's ROE of +1.75%. Regarding short-term risk, PNTG is more volatile compared to TVTY. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check TVTY's competition here
New Frontier Health Corporation (NYSE: NFH)
PNTG vs NFH Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, NFH has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while NFH trades at $11.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas NFH's P/E ratio is -19.75. In terms of profitability, PNTG's ROE is +0.09%, compared to NFH's ROE of -0.06%. Regarding short-term risk, PNTG is more volatile compared to NFH. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check NFH's competition here
Skylight Health Group Inc. (NASDAQ: SLHGP)
PNTG vs SLHGP Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SLHGP has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SLHGP trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SLHGP's P/E ratio is -30.38. In terms of profitability, PNTG's ROE is +0.09%, compared to SLHGP's ROE of -0.48%. Regarding short-term risk, PNTG is more volatile compared to SLHGP. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check SLHGP's competition here
Skylight Health Group Inc. (NASDAQ: SLHG)
PNTG vs SLHG Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, SLHG has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while SLHG trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas SLHG's P/E ratio is -1.48. In terms of profitability, PNTG's ROE is +0.09%, compared to SLHG's ROE of N/A. Regarding short-term risk, PNTG is less volatile compared to SLHG. This indicates lower risk in terms of short-term price fluctuations for PNTG.Check SLHG's competition here
Diversicare Healthcare Services, Inc. (NASDAQ: DVCR)
PNTG vs DVCR Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, DVCR has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while DVCR trades at $10.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas DVCR's P/E ratio is 28.34. In terms of profitability, PNTG's ROE is +0.09%, compared to DVCR's ROE of -0.15%. Regarding short-term risk, PNTG is more volatile compared to DVCR. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check DVCR's competition here
Almost Family Inc. (NASDAQ: AFAM)
PNTG vs AFAM Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, AFAM has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while AFAM trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas AFAM's P/E ratio is N/A. In terms of profitability, PNTG's ROE is +0.09%, compared to AFAM's ROE of +0.06%. Regarding short-term risk, PNTG is more volatile compared to AFAM. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check AFAM's competition here
SOC Telemed, Inc. (NASDAQ: TLMD)
PNTG vs TLMD Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, TLMD has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while TLMD trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas TLMD's P/E ratio is -1.60. In terms of profitability, PNTG's ROE is +0.09%, compared to TLMD's ROE of -0.46%. Regarding short-term risk, PNTG is more volatile compared to TLMD. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check TLMD's competition here
Kindred Healthcare, Inc. (NYSE: KND)
PNTG vs KND Comparison July 2026
The Pennant Group, Inc. (NASDAQ: PNTG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, PNTG stands at 1.4B. In comparison, KND has a market cap of 0. Regarding current trading prices, PNTG is priced at $41.16 on the NASDAQ, while KND trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
PNTG currently has a P/E ratio of 33.46, whereas KND's P/E ratio is -1.14. In terms of profitability, PNTG's ROE is +0.09%, compared to KND's ROE of -0.53%. Regarding short-term risk, PNTG is more volatile compared to KND. This indicates higher risk in terms of short-term price fluctuations for PNTG.Check KND's competition here